Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

Recruiting N/A Interventional Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
110 (estimated)
Sponsor
Thomas Jefferson University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medica…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients on oral chemotherapeutic agents * Clinical diagnosis of stage IV breast cancer * Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrent radiation therapy) * Clinical diagnosis of stage IV non-small cell lung cancer * Clinical diagnosis …
Contacts

Claudia M Dourado, MD

215-456-3880

Douradoc@einstein.edu

CONTACT

Claudia Dourado

215-456-3880

Douradoc@einstein.edu

CONTACT